Ítem
Acceso Abierto

Experiencia en nefrectomía: serie de casos de cuatro años

Mostrar el registro sencillo de la publicación
dc.contributor.advisorSalgado Tovar, Javier Mauricio
dc.creatorSoto Morales, Claudio Giovanni
dc.creator.degreeEspecialista en Urología
dc.date.accessioned2014-02-12T12:47:32Z
dc.date.available2014-02-12T12:47:32Z
dc.date.created2014-01-20
dc.date.issued2014
dc.descriptionIntroducción: Las indicaciones por las cuales un paciente requiere una nefrectomía son múltiples: las neoplasias, la hidronefrosis y la exclusión funcional son las principales. En manos expertas la nefrectomía es un procedimiento seguro, especialmente porque en la actualidad el abordaje por excelencia es realizar una técnica mínimamente invasiva con conservación de nefronas. Se presenta el análisis de la experiencia en Mederi, Hospital Universitario Mayor en esta intervención. Metodología: Se realizó una serie de casos de pacientes llevados a nefrectomía entre mayo de 2008 y mayo de 2012. Se incluyeron la totalidad de los casos. Resultados: Se analizaron 72 registros, 49 mujeres y 25 hombres; 13 de ellas fueron laparoscópicas. La edad promedio fue de 58,6 años. El tiempo medio operatorio fue 169,23 minutos (118-220 minutos). El sangrado operatorio promedio fue de 680,63 ml (IC95%: 2,83-1358 ml). El tiempo de hospitalización promedio fue de 4,88 días IC95%. La mayoría de los pacientes se distribuyeron en estadios medios de la enfermedad tumoral, con poco compromiso ganglionar y metástasis; el diagnóstico histológico y estadio dominante fueron el carcinoma de células renales grado 3 de Fuhrman respectivamente. Se reportan 13 casos de compromiso de la capsula de Gerota y 11 con compromiso del hilio. Discusión: La experiencia en nefrectomía de la institución es muy positiva por el bajo número de mortalidad y complicaciones. En cuanto a la técnica, es importante promover la técnica laparoscópicaspa
dc.description.abstractIntroduction: The indications for a patient to require a nephrectomy are multiples, neoplasms, hydronephrosis and functional exclusion are the main causes. In experienced hands nephrectomy is a safe procedure, especially because nowadays the main approach is to perform a minimally invasive technique with nephron sparing. Analysis of the experience in Mederi is shown in this study. Methods A case series of patients who underwent nephrectomy between May 2008 and May 2012 was performed. All cases were included. Results 72 records, 49 women and 25 men were analyzed, 13 of which were laparoscopic. The average age was 58. 6 years. The average operative time was 169. 23 minutes (118- 220minutes). The mean operative blood loss was 680. 63 ml. The mean hospital stay was 4. 88 days, most patients were distributed in the middle stages of tumor disease, with little nodal involvement and metastasis, histological diagnosis and were the dominant stage renal cell carcinoma Fuhrman stage 3 respectively, 13 cases of Gerota `s capsule commitment and 11 cases with renal hilum commitment. The concordance between the imaging diagnosis (clinical) and intraoperative finding was moderate (κ0. 46). Discussion Nephrectomy experience of the institution is very positive because of the low number of complications and mortality. As for the technique, it is important to promote the laparoscopic one. eng
dc.format.mimetypeapplication/pdf
dc.format.tipoDocumentospa
dc.identifier.doihttps://doi.org/10.48713/10336_4887
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/4887
dc.language.isospa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentFacultad de Medicinaspa
dc.publisher.programEspecialización en Urologíaspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto completo)spa
dc.rights.ccAtribución-NoComercial-SinDerivadas 2.5 Colombiaspa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.source.bibliographicCitationET Bell, Tumors of the kidney Ed. Publishers Philadelphia 1950.
dc.source.bibliographicCitationCampbell NA Wright. Endotoxin and acute renal failure associated with obstructive jaundice. British medical journal 4(5733): 472–474. 1970
dc.source.bibliographicCitationSchulam et al. Cost of cancer care. American society of clinical oncology. Vol. 25, No. 2, 180-186, 2007
dc.source.bibliographicCitationSiegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J Clin; 614: 212–36. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21685461
dc.source.bibliographicCitationLandis Sara, Murray T et al. Cancer statistics, 1999. A cancer journal for clinicians. Vol 4 Issue 1. Pag 8-31
dc.source.bibliographicCitationYossepowitch, Houston R, Thompson, Russo et al, Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. The journal of urology Vol 179 issue 6. 2008
dc.source.bibliographicCitationCarrizosa y Godley, Epidemiology and screening of renal cell carcinoma PMPH-USA, 2009
dc.source.bibliographicCitationJemal A Siegel R Ward et al, Cancer statistics Vol 59 Issue 4 225-249 2009.
dc.source.bibliographicCitationWallen F, Kelly Smith et al. Impact of hospital type on surgical treatment for kidney cancer: recent trends. Journal of urology. Elsevier, 2007
dc.source.bibliographicCitationGJ DeCastro, JM McKiernon, Epidemiology and clinical staging and presentation of renal cell carcinoma. Urologic Clinics of North America. Elsevier, 2008
dc.source.bibliographicCitationWoldrich, Mailin, Ritchie, Carrol et al. Sex differences in renal cell cancer presentation and survival. An analysis of the national cancer database 1993 – 2004. Vol 179 Issue 5 May 2008; pages 1709 - 1713
dc.source.bibliographicCitationMcKiernan JM, Teschendorf B, Katz J, Herr HW, Russo P. A comparison of hospital-based charges following partial and radical nephrectomy. Urol. Oncol. [Internet]. [cited 2013 Sep 12];71:3–6. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/1247453
dc.source.bibliographicCitationRobson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J. Urol. [Internet]. 1969 Mar [cited 2013 Dec 17];101(3):297–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/5765875
dc.source.bibliographicCitationSkinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer [Internet]. 1971 Nov [cited 2013 Dec 17];28(5):1165–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/5125665
dc.source.bibliographicCitationJemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. Cancer J. Clin. [Internet]. [cited 2013 Sep 12];612:69–90. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/2129685
dc.source.bibliographicCitationJin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, et al. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int. J. Cancer [Internet]. 1999 Nov 12 [cited 2013 Dec 17];83(4):435–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10508476 17. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer [Internet]. 2010 Mar [cited 2013 Aug 8];464:765–81. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/20116997 18. Varela R, Donoso W, Corredor H. Experiencia de nefrectomía radical en el Instituto Nacional de Cancerología. Bogotá, Colombia. Serie de casos. Urol. Colomb. [Internet]. 2010 [cited 2013 Oct 5];XIX2:39–44. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3423529 19. Thyavihally Y. Management of renal cell carcinoma with solitary metastasis. World J Urol [Internet]. 2005 [cited 2013 Aug 28];9:1–9. Disponible en:: http://www.biomedcentral.com/1477-7819/3/48 20. Beisland C, Medby PC, Beisland HO. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scand. J. Urol. Nephrol. [Internet]. 2004 Jan;384:299–305. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/15669589 21. Shekarriz B, Upadhyay J, Shekarriz H, de Assis Mendes Goes F, Bianco FJ, Tiguert R, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology [Internet]. 2002 Feb [cited 2013 Sep 12];592:211–5. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/11834387 22. Cairns P. Renal cell carcinoma. Cancer Biomark. [Internet]. 2010 Jan [cited 2013 Sep 12]; 91 - 6: 461 – 73. www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308682&tool=pmcentrez&rendertype=abstract 23. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J. Urol. [Internet]. 2006 Dec [cited 2013 Dec 17];176(6 Pt 1):2353–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17085101 24. Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol. [Internet]. 2008 May [cited 2013 Dec 17];179(5):1704–8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2677163&tool=pmcentrez&rendertype=abstract 25. Kümmerlin IPED, ten Kate FJW, Wijkstra H, de la Rosette JJMCH, Laguna MP. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. [Internet]. 2008 Oct [cited 2013 Dec 17];102(8):946–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18564136 26. Konnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J. Urol. [Internet]. 1985 Dec [cited 2013 Dec 17];134(6):1094–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4057398 27. Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor. J. Urol. [Internet]. 1988 Sep [cited 2013 Dec 17];140(3):487–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3411657 28. Kessler O, Mukamel E, Hadar H, Gillon G, Konechezky M, Servadio C. Effect of improved diagnosis of renal cell carcinoma on the course of the disease. J. Surg. Oncol. [Internet]. 1994 Nov [cited 2013 Dec 17];57(3):201–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7967611 29. Parsons JK, Schoenberg MS, Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology [Internet]. 2001 Jun [cited 2013 Dec 17];57(6):1013–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11377295 30. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer [Internet]. 2008 Jul 1 [cited 2013 Dec 17];113(1):78–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18491376 31. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J. Urol. [Internet]. 2002 Jan [cited 2013 Dec 17];167(1):57–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11743275 32. Wallen EM, Pruthi RS, Joyce GF, Wise M. Kidney cancer. J. Urol. [Internet]. 2007 Jun [cited 2013 Dec 17];177(6):2006–18; discussion 2018–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509280 33. Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol. Clin. North Am. [Internet]. 2008 Nov [cited 2013 Dec 17];35(4):581–92; vi. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18992612 34. Sanders PW. Pathogenesis and treatment of myeloma kidney. J. Lab. Clin. Med. [Internet]. 1994 Oct [cited 2013 Dec 17];124(4):484–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7930873 35. Sufrin G, Chasan S, Golio A, Murphy GP. Paraneoplastic and serologic syndromes of renal adenocarcinoma. Semin. Urol. [Internet]. 1989 Aug [cited 2013 Dec 17];7(3):158–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2690260 36. Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin. Urol. Oncol. [Internet]. 1996 Nov [cited 2013 Dec 17];14(4):216–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8946620 37. Moein MR, Dehghani VO. Hypertension: a rare presentation of renal cell carcinoma. J. Urol. [Internet]. 2000 Dec [cited 2013 Dec 17];164(6):2019. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061907 38. Wiesener MS, Seyfarth M, Warnecke C, Jürgensen JS, Rosenberger C, Morgan N V, et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood [Internet]. 2002 May 15 [cited 2013 Dec 17];99(10):3562–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11986208 39. Kamra D, Boselli J, Sloane BB, Gladstone DE. Renal cell carcinoma induced Coombs negative autoimmune hemolytic anemia and severe thrombocytopenia responsive to nephrectomy. J. Urol. [Internet]. 2002 Mar [cited 2013 Dec 17];167(3):1395. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11832746 40. Hagel C, Stavrou D, Hansen HC. Paraneoplastic frontal lobe disorder and ataxia in renal cell carcinoma. Neuropathol. Appl. Neurobiol. [Internet]. 2005 Feb [cited 2013 Dec 17];31(1):97–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15634236 41. Costanzi S, Zoli A, Ferraro PM, Danza FM, Ferraccioli GF. A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. Clin. Nephrol. [Internet]. 2008 Aug [cited 2013 Dec 17];70(2):172–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18793535 42. Moazzam M, Ather MH, Hussainy AS. Leiomyosarcoma presenting as a spontaneously ruptured renal tumor-case report. BMC Urol. [Internet]. 2002 Nov 19 [cited 2013 Dec 17];2:13. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138801&tool=pmcentrez&rendertype=abstract 43. Elias AN. New-onset insulinopenic diabetes mellitus in a patient with an incidentally discovered renal cell carcinoma. Am. J. Med. [Internet]. 2005 Sep [cited 2013 Dec 17];118(9):1047–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16164894 44. Khatri V, Asensio J. Operative surgery manual [Internet]. 2003 [cited 2013 Oct 8]. Disponible en:: http://www.lavoisier.fr/livre/notice.asp?ouvrage=1517546 45. Batata M, Grabstald H. Upper urinary tract urothelial tumors. Urol Clin North Am. 1976;3:79–86. 46. Herr H. Long-term results of BCG therapy: concern about upper tract tumors. Semin Urol Oncol. 1998;16:13–6. 47. Lane B, Campbell S, Poggio E, Al. E. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182:4335–444. 48. Rini B, Campbell S, Escudier B. Renal cell carcinoma. Lancet. 2009;373:1119–32. 49. Fuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;7:655–63. 50. Dall’Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J. Urol. [Internet]. 2007 May [cited 2013 Aug 28];1775:1687–91. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/17437783 51. Sánchez Zalabardo D, Arocena García-Tapia J, Regojo Balboa JM, Fernández Montero JM, López Ferrandis J, Rosell Costa D, et al. Factores pronóstico en carcinoma renal pT3. Actas Urol. Esp. [Internet]. Elsevier España S. L.; 2003 Jan [cited 2013 Oct 28];271:26–32. Disponible en:: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062003000100006&lng=es&nrm=iso&tlng=e 52. Lacombe M. Renal arteriovenous fistula following nephrectomy. Urology [Internet]. 1985 Jan [cited 2014 Jan 22];25(1):13–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3966275 53. Okamoto M, Hashimoto M, Akita T, Sueda T, Karakawa S, Ohishi Y, et al. Congestive heart failure caused by aortocaval fistula after nephrectomy. Intern. Med. [Internet]. 2001 Nov [cited 2014 Jan 22];40(11):1113–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11757766 54. Escobar F, Gaviria F, Castellanos R, Aristizabal J, Arbélaez S, Bonilla A, et al. Nefrectomia radical laparoscópica. Análisis de una serie de casos. Rev. Urol. Colomb. [Internet]. Sociedad Colombiana de Urología; 2005 55. Castillo C O, Sánchez-Salas R, Vidal M I, Vitagliano G, Díaz C M, Fonerón V A, et al. Complicaciones en nefrectomía parcial laparoscópica por tumores renales: análisis de 147 pacientes operados en forma consecutiva. Rev. Chil. cirugía [Internet]. Sociedad de Cirujanos de Chile; 2008 Jun [cited 2013 Nov 14];603:219–25. Disponible en:: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262008000300009&lng=es&nrm=iso&tlng=es 56. L MK, G RO. Nefrectomía radical laparoscópica en el tratamiento del carcinoma de células renales: análisis de los primeros 50 casos. Rev Chil Urol [Internet]. 2006 [cited 2013 Nov 14]; Disponible en:: http://www.revistacirugia.cl/PDF Cirujanos 2006_02/Cir.22006.09.pdf 57. Bazán A, González S. Análisis comparativo de la nefrectomía parcial abierta versus laparoscópica en el tratamiento del tumor renal. Rev Arg Urol [Internet]. 2013 [cited 2013 Nov 14]; Disponible en:: http://www.revistasau.org/index.php/revista/article/viewFile/3369/3282 58. Husillos Alonso A, Subirá Ríos D, López López E, Ogaya Piniés G, Piñero Sánchez Ja, Aragón Chamizo J, et al. Resección laparoscópica pura de la recurrencia local del cáncer renal tras nefrectomía con intención curativa: análisis de la técnica quirúrgica y seguimiento oncológico de una serie de 8 casos. LXXVII Congr. Nac. Urol. 2012 59. Tolosa Eizaguirre E, Pascual Piédrola I, Barba Abad JF, Rincón Mayans A, Romero Vargas LM, Zudaire JJ. Nefrectomía parcial laparoscópica.: Análisis de los primeros 30 casos de nuestra serie y revisión de la literatura [Internet]. Actas urológicas españolas Organo Of. difusión la Asoc. Española Urol. Ene; 2010 [cited 2013 Nov 14]. p. 798–801. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3278159&info=resumen&idioma=SPA
dc.source.bibliographicCitationFerlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer [Internet]. 2010 Mar [cited 2013 Aug 8];464:765–81. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/20116997
dc.source.bibliographicCitationVarela R, Donoso W, Corredor H. Experiencia de nefrectomía radical en el Instituto Nacional de Cancerología. Bogotá, Colombia. Serie de casos. Urol. Colomb. [Internet]. 2010 [cited 2013 Oct 5];XIX2:39–44. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3423529
dc.source.bibliographicCitationThyavihally Y. Management of renal cell carcinoma with solitary metastasis. World J Urol [Internet]. 2005 [cited 2013 Aug 28];9:1–9. Disponible en:: http://www.biomedcentral.com/1477-7819/3/48
dc.source.bibliographicCitationBeisland C, Medby PC, Beisland HO. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scand. J. Urol. Nephrol. [Internet]. 2004 Jan;384:299–305. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/15669589
dc.source.bibliographicCitationShekarriz B, Upadhyay J, Shekarriz H, de Assis Mendes Goes F, Bianco FJ, Tiguert R, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology [Internet]. 2002 Feb [cited 2013 Sep 12];592:211–5. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/11834387
dc.source.bibliographicCitationCairns P. Renal cell carcinoma. Cancer Biomark. [Internet]. 2010 Jan [cited 2013 Sep 12]; 91 - 6: 461 – 73. www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308682&tool=pmcentrez&rendertype=abstract
dc.source.bibliographicCitationLipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J. Urol. [Internet]. 2006 Dec [cited 2013 Dec 17];176(6 Pt 1):2353–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17085101
dc.source.bibliographicCitationStafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol. [Internet]. 2008 May [cited 2013 Dec 17];179(5):1704–8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2677163&tool=pmcentrez&rendertype=abstract
dc.source.bibliographicCitationKümmerlin IPED, ten Kate FJW, Wijkstra H, de la Rosette JJMCH, Laguna MP. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. [Internet]. 2008 Oct [cited 2013 Dec 17];102(8):946–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18564136
dc.source.bibliographicCitationKonnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J. Urol. [Internet]. 1985 Dec [cited 2013 Dec 17];134(6):1094–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4057398
dc.source.bibliographicCitationThompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor. J. Urol. [Internet]. 1988 Sep [cited 2013 Dec 17];140(3):487–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3411657
dc.source.bibliographicCitationKessler O, Mukamel E, Hadar H, Gillon G, Konechezky M, Servadio C. Effect of improved diagnosis of renal cell carcinoma on the course of the disease. J. Surg. Oncol. [Internet]. 1994 Nov [cited 2013 Dec 17];57(3):201–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7967611
dc.source.bibliographicCitationParsons JK, Schoenberg MS, Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology [Internet]. 2001 Jun [cited 2013 Dec 17];57(6):1013–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11377295
dc.source.bibliographicCitationKane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer [Internet]. 2008 Jul 1 [cited 2013 Dec 17];113(1):78–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18491376
dc.source.bibliographicCitationHock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J. Urol. [Internet]. 2002 Jan [cited 2013 Dec 17];167(1):57–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11743275
dc.source.bibliographicCitationWallen EM, Pruthi RS, Joyce GF, Wise M. Kidney cancer. J. Urol. [Internet]. 2007 Jun [cited 2013 Dec 17];177(6):2006–18; discussion 2018–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509280
dc.source.bibliographicCitationDecastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol. Clin. North Am. [Internet]. 2008 Nov [cited 2013 Dec 17];35(4):581–92; vi. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18992612
dc.source.bibliographicCitationSanders PW. Pathogenesis and treatment of myeloma kidney. J. Lab. Clin. Med. [Internet]. 1994 Oct [cited 2013 Dec 17];124(4):484–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7930873
dc.source.bibliographicCitationSufrin G, Chasan S, Golio A, Murphy GP. Paraneoplastic and serologic syndromes of renal adenocarcinoma. Semin. Urol. [Internet]. 1989 Aug [cited 2013 Dec 17];7(3):158–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2690260
dc.source.bibliographicCitationGold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin. Urol. Oncol. [Internet]. 1996 Nov [cited 2013 Dec 17];14(4):216–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8946620
dc.source.bibliographicCitationMoein MR, Dehghani VO. Hypertension: a rare presentation of renal cell carcinoma. J. Urol. [Internet]. 2000 Dec [cited 2013 Dec 17];164(6):2019. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061907
dc.source.bibliographicCitationWiesener MS, Seyfarth M, Warnecke C, Jürgensen JS, Rosenberger C, Morgan N V, et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood [Internet]. 2002 May 15 [cited 2013 Dec 17];99(10):3562–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11986208
dc.source.bibliographicCitationKamra D, Boselli J, Sloane BB, Gladstone DE. Renal cell carcinoma induced Coombs negative autoimmune hemolytic anemia and severe thrombocytopenia responsive to nephrectomy. J. Urol. [Internet]. 2002 Mar [cited 2013 Dec 17];167(3):1395. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11832746
dc.source.bibliographicCitationHagel C, Stavrou D, Hansen HC. Paraneoplastic frontal lobe disorder and ataxia in renal cell carcinoma. Neuropathol. Appl. Neurobiol. [Internet]. 2005 Feb [cited 2013 Dec 17];31(1):97–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15634236
dc.source.bibliographicCitationCostanzi S, Zoli A, Ferraro PM, Danza FM, Ferraccioli GF. A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. Clin. Nephrol. [Internet]. 2008 Aug [cited 2013 Dec 17];70(2):172–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18793535
dc.source.bibliographicCitationMoazzam M, Ather MH, Hussainy AS. Leiomyosarcoma presenting as a spontaneously ruptured renal tumor-case report. BMC Urol. [Internet]. 2002 Nov 19 [cited 2013 Dec 17];2:13. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138801&tool=pmcentrez&rendertype=abstract
dc.source.bibliographicCitationElias AN. New-onset insulinopenic diabetes mellitus in a patient with an incidentally discovered renal cell carcinoma. Am. J. Med. [Internet]. 2005 Sep [cited 2013 Dec 17];118(9):1047–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16164894
dc.source.bibliographicCitationKhatri V, Asensio J. Operative surgery manual [Internet]. 2003 [cited 2013 Oct 8]. Disponible en:: http://www.lavoisier.fr/livre/notice.asp?ouvrage=1517546
dc.source.bibliographicCitationBatata M, Grabstald H. Upper urinary tract urothelial tumors. Urol Clin North Am. 1976;3:79–86.
dc.source.bibliographicCitationHerr H. Long-term results of BCG therapy: concern about upper tract tumors. Semin Urol Oncol. 1998;16:13–6.
dc.source.bibliographicCitationLane B, Campbell S, Poggio E, Al. E. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182:4335–444.
dc.source.bibliographicCitationRini B, Campbell S, Escudier B. Renal cell carcinoma. Lancet. 2009;373:1119–32.
dc.source.bibliographicCitationFuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;7:655–63.
dc.source.bibliographicCitationDall’Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J. Urol. [Internet]. 2007 May [cited 2013 Aug 28];1775:1687–91. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/17437783
dc.source.bibliographicCitationSánchez Zalabardo D, Arocena García-Tapia J, Regojo Balboa JM, Fernández Montero JM, López Ferrandis J, Rosell Costa D, et al. Factores pronóstico en carcinoma renal pT3. Actas Urol. Esp. [Internet]. Elsevier España S. L.; 2003 Jan [cited 2013 Oct 28];271:26–32. Disponible en:: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062003000100006&lng=es&nrm=iso&tlng=e
dc.source.bibliographicCitationLacombe M. Renal arteriovenous fistula following nephrectomy. Urology [Internet]. 1985 Jan [cited 2014 Jan 22];25(1):13–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3966275
dc.source.bibliographicCitationOkamoto M, Hashimoto M, Akita T, Sueda T, Karakawa S, Ohishi Y, et al. Congestive heart failure caused by aortocaval fistula after nephrectomy. Intern. Med. [Internet]. 2001 Nov [cited 2014 Jan 22];40(11):1113–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11757766
dc.source.bibliographicCitationEscobar F, Gaviria F, Castellanos R, Aristizabal J, Arbélaez S, Bonilla A, et al. Nefrectomia radical laparoscópica. Análisis de una serie de casos. Rev. Urol. Colomb. [Internet]. Sociedad Colombiana de Urología; 2005
dc.source.bibliographicCitationCastillo C O, Sánchez-Salas R, Vidal M I, Vitagliano G, Díaz C M, Fonerón V A, et al. Complicaciones en nefrectomía parcial laparoscópica por tumores renales: análisis de 147 pacientes operados en forma consecutiva. Rev. Chil. cirugía [Internet]. Sociedad de Cirujanos de Chile; 2008 Jun [cited 2013 Nov 14];603:219–25. Disponible en:: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262008000300009&lng=es&nrm=iso&tlng=es
dc.source.bibliographicCitationL MK, G RO. Nefrectomía radical laparoscópica en el tratamiento del carcinoma de células renales: análisis de los primeros 50 casos. Rev Chil Urol [Internet]. 2006 [cited 2013 Nov 14]; Disponible en:: http://www.revistacirugia.cl/PDF Cirujanos 2006_02/Cir.22006.09.pdf
dc.source.bibliographicCitationBazán A, González S. Análisis comparativo de la nefrectomía parcial abierta versus laparoscópica en el tratamiento del tumor renal. Rev Arg Urol [Internet]. 2013 [cited 2013 Nov 14]; Disponible en:: http://www.revistasau.org/index.php/revista/article/viewFile/3369/3282
dc.source.bibliographicCitationHusillos Alonso A, Subirá Ríos D, López López E, Ogaya Piniés G, Piñero Sánchez Ja, Aragón Chamizo J, et al. Resección laparoscópica pura de la recurrencia local del cáncer renal tras nefrectomía con intención curativa: análisis de la técnica quirúrgica y seguimiento oncológico de una serie de 8 casos. LXXVII Congr. Nac. Urol. 2012
dc.source.bibliographicCitationTolosa Eizaguirre E, Pascual Piédrola I, Barba Abad JF, Rincón Mayans A, Romero Vargas LM, Zudaire JJ. Nefrectomía parcial laparoscópica.: Análisis de los primeros 30 casos de nuestra serie y revisión de la literatura [Internet]. Actas urológicas españolas Organo Of. difusión la Asoc. Española Urol. Ene; 2010 [cited 2013 Nov 14]. p. 798–801. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3278159&info=resumen&idioma=SPA
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subjectnefrectomíaspa
dc.subject.decsNEFRECTOMÍAspa
dc.subject.keywordnephrectomyeng
dc.titleExperiencia en nefrectomía: serie de casos de cuatro añosspa
dc.typemasterThesiseng
dc.type.hasVersioninfo:eu-repo/semantics/submittedVersion
dc.type.spaTrabajo de gradospa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
SotoMorales-ClaudioGiovanni-2014.pdf
Tamaño:
2.94 MB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Especialización en Urología